AEM: Comeback is Real As It Sweeps Intel Award, Stock Skyrockets, DBS Raises Target Price Again

After several years of struggling with operational issues, including litigation, and a semiconductor downcycle, AEM Holdings is finally catching its second wind.

AEM is in the midst of a dramatic turnaround, especially since the release of its robust FY25 results in February, evidenced by a surging share price—up approximately 138% year-to-date (from $1.74 to $4.10).

Now, there's a prestigious nod from its most critical customer, Intel Corp.

AEM (market cap: S$1.3 billion) announced it has received the 2026 Intel EPIC Supplier Award, the highest tier of recognition within Intel’s global supply chain.

This award, given to only 41 suppliers out of thousands, recognises AEM for its "excellence in quality, technology innovation, operational performance, and continuous improvement."

mgt 11.25

DBS Group Research published a bullish update on March 20, reinforcing the "Buy" case for the stock.

DBS raised its target price to $4.60 (up from $3.30), citing a "valuation uplift" driven by AI tailwinds and successful customer diversification.

That is now the most bullish target, while the targets of other analysts have been surpassed by the stock:

Brokerage	Analyst	Previous TP	New TP
DBS	Amanda Tan	S$3.30	S$4.60
CGS Int'l	William Tng	S$1.85	S$3.14
Maybank	Jarick Seet	S$1.49	S$2.84
UOB Kay Hian	John Cheong	S$1.51	S$2.65

Key Takeaways From DBS Report:

1. Technological Lead in System Level Test (SLT)

DBS analyst Amanda Tan notes that AEM remains approximately one generation ahead of its competitors in SLT solutions.

As chips become more complex (thanks to 5G, AI, and IoT), the industry requires more intensive testing. AEM’s "technological superiority" positions it to capture the lion's share of this growing spend.

2. The Intel "4nm" Transition

A major driver for AEM is Intel’s shift toward more advanced nodes.

Intel is currently preparing for the mass production of 4nm chips. These smaller, more complex nodes require significantly longer test times, which directly translates to:

Higher demand for AEM’s high-density modular test (HDMT) handlers.
Increased revenue from consumables due to higher wear and tear during longer test cycles.

3. Rapid Customer Diversification

AEM is no longer just "the Intel play." DBS highlights that traction with new customers is gaining steam:

AI Fabless Customers: Revenue from this segment is expected to more than double in FY26.
Memory Customers: Orders for final test handlers are on track, with initial revenues expected in late FY26 ahead of a major production ramp in 2027.

4. The "Hyperscaler" Opportunity

DBS points to a massive, untapped upside: Big Tech "hyperscalers" (cloud providers) are increasingly designing their own silicon.

Currently, many use inefficient lab-style tools for production testing.

AEM’s high-parallel test equipment is "favourably positioned" to replace these inefficient systems, providing a potential earnings catalyst not yet fully priced into the stock.

Financial Outlook (FY25–FY27)

DBS forecasts a powerful earnings recovery, with net profit expected to jump from $17.1m in 2025 to $45.1m by 2027.

While a residual legal overhang and relatively small market cap keep AEM at a slight discount to global peers like Advantest and Teradyne, DBS believes the risk-reward remains "skewed to the upside."

Valuation of global test peers:

Company Name	FY End	CY-2025	CY-2026	CY-2027	CY-2028
Advantest Corporation	Mar	49.2	41.5	31.9	31.6
TERADYNE, INC	Dec	48.9	47.9	36.2	28.9
Chroma Ate Inc.	Dec	28.2	45.6	35.3	30.3
Average		42.1	45.0	34.4	30.3
Source: Visible Alpha, DBS